Novel hydrazone derivatives of 7-hydroxy-3',3'-dimethyl-3'H-spiro[chromene-2,1'-isobenzofuran]-8-carbaldehyde.

The structures of new oxaindane spiropyrans derived from 7-hydroxy-3',3'-dimethyl-3'H-spiro[chromene-2,1'-isobenzofuran]-8-carbaldehyde (SP1), namely N-benzyl-2-[(7-hydroxy-3',3'-dimethyl-3'H-spiro[chromene-2,1'-isobenzofuran]-8-yl)methylidene]hydrazinecarbothioamide, C(27)H(25)N(3)O(3)S, (I), at 120 (2) K, and N'-[(7-hydroxy-3',3'-dimethyl-3'H-spiro[chromene-2,1'-isobenzofuran]-8-yl)methylidene]-4-methylbenzohydrazide acetone monosolvate, C(27)H(24)N(2)O(4)·C(3)H(6)O, (II), at 100 (2) K, are reported. The photochromically active C(spiro)-O bond length in (I) is close to that in the parent compound (SP1), and in (II) it is shorter. In (I), centrosymmetric pairs of molecules are bound by two equivalent N-H.

A novel chelatofore functionalized spiropyran of the 2-oxaindane series.

A novel chelatofore functionalized spiropyran of the 2-oxaindane series, namely 8-formyl-7-hydroxy-3',3'-dimethylspiro[2H-chromene-2,1'(3'H)-2-benzofuran], C(19)H(16)O(4), is reported. In the crystalline state, dimers are formed as a result of the pi-pi stacking of aromatic groups of the 2H-chromene part of the molecule and C-H..

[A morphological assessment of the efficacy of the deaggregation therapy of chronic catarrhal gingivitis].

Light optics, electron microscopy, morphometry were used to study the structural changes in the epithelial cells and endotheliocytes of gingival papillary capillaries of patients with chronic catarrhal gingivitis after papaverin therapy. The studies have revealed signs of disappearance of intercellular edema and a higher degree of cellular differentiation; signs of normalization of transcellular fluid transport were seen in the endotheliocytes, and aggregations of formed elements of the blood disappeared.